CER, PMS, PMCF, PSUR, SSCP

Home / MS & CE Marking Consultancy

Key Regulatory Documentation for MDR 2017/745 & IVDR 2017/746

At EUmAccess GmbH, we assist medical device and in vitro diagnostic (IVD) manufacturers in preparing and maintaining critical regulatory documents, ensuring compliance with EU MDR 2017/745 and IVDR 2017/746.

Below is an overview of the essential documents required for CE Marking, post-market surveillance, and regulatory compliance:

Clinical Evaluation Report (CER) – MDR 2017/745

  • What is a CER?
    • A Clinical Evaluation Report (CER) demonstrates that a medical device meets safety and performance requirements based on clinical data. It is required for all devices under MDR 2017/745 and is continuously updated throughout the device lifecycle.

  • Key Requirements (MDR Annex XIV, Part A & MEDDEV 2.7/1 Rev. 4)

    • Systematic literature review & clinical investigation data
    • Equivalence assessment with similar devices (if applicable)
    • Post-market clinical follow-up (PMCF) integration
    • Risk-benefit analysis & clinical validation

  • How We Help

    • CER writing & gap analysis
    • Clinical data collection & evaluation
    • Notified Body review support

Post-Market Surveillance (PMS) – MDR & IVDR

  • What is PMS?
    • Post-Market Surveillance (PMS) is an ongoing process that monitors device safety, performance, and compliance after market launch.

 

  • Key Requirements (MDR Chapter VII, IVDR Chapter VII)
    • Establishing a PMS Plan (MDR Annex III)
    • Collecting & analyzing real-world data
    • Updating risk management & clinical evaluation documents
    • Reporting adverse events & trends

 

  • How We Help
    • PMS Plan development & implementation
    • Data collection & reporting
    • Compliance with EUDAMED & Competent Authorities

Post-Market Clinical Follow-Up (PMCF) – MDR 2017/745

  • What is PMCF?
    • Post-Market Clinical Follow-Up (PMCF) is part of PMS and ensures ongoing clinical safety & performance assessment.

  • Key Requirements (MDR Annex XIV, Part B)
    • Continuous collection of clinical data
    • Addressing residual risks & long-term safety concerns
    • Justifying non-performance of PMCF (if applicable)

  • How We Help
    • PMCF Plan & Report development
    • Clinical study design & execution
    • Integration with CER & risk management
04

Periodic Safety Update Report (PSUR) – MDR & IVDR

  • What is PSUR?
    • The Periodic Safety Update Report (PSUR) provides an annual safety & performance review for Class IIa, IIb, and III medical devices.

  • Key Requirements (MDR Article 86, IVDR Article 81)
    • Aggregated safety data analysis
    • Risk-benefit assessment updates
    • Integration with PMS & PMCF findings

  • How We Help
    • PSUR preparation & submission
    • Compliance monitoring & Notified Body coordination
    • Risk management updates
05

Summary of Safety and Clinical Performance (SSCP) – MDR 2017/745

  • What is SSCP?
    • The Summary of Safety and Clinical Performance (SSCP) provides transparent clinical information to healthcare professionals & patients for Class III and implantable medical devices.

  • Key Requirements (MDR Article 32)
    • Device description & intended use
    • Summary of clinical data & PMCF findings
    • Residual risks & safety measures
    • Published in EUDAMED & accessible to the public

  • How We Help
    • SSCP preparation & compliance review
    • EUDAMED submission support
    • Translation & readability assessment

Why Choose EUmAccess GmbH?

  • Regulatory Experts – Ensuring seamless MDR & IVDR compliance
  • End-to-End Documentation Support – From CER to SSCP
  • Notified Body & Competent Authority Compliance
  • Efficient & Reliable Process – Minimize delays & regulatory risks
TOP